IS6678A - Hvarfefni og prófanir fyrir ß-sekretasavirkni - Google Patents
Hvarfefni og prófanir fyrir ß-sekretasavirkniInfo
- Publication number
- IS6678A IS6678A IS6678A IS6678A IS6678A IS 6678 A IS6678 A IS 6678A IS 6678 A IS6678 A IS 6678A IS 6678 A IS6678 A IS 6678A IS 6678 A IS6678 A IS 6678A
- Authority
- IS
- Iceland
- Prior art keywords
- reagents
- tests
- secretory activity
- substrates
- asp
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21979500P | 2000-07-19 | 2000-07-19 | |
US27525101P | 2001-03-12 | 2001-03-12 | |
PCT/US2001/023035 WO2002006306A2 (en) | 2000-07-19 | 2001-07-19 | SUBSTRATES AND ASSAYS FOR β-SECRETASE ACTIVITY |
Publications (1)
Publication Number | Publication Date |
---|---|
IS6678A true IS6678A (is) | 2003-01-14 |
Family
ID=26914256
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS6678A IS6678A (is) | 2000-07-19 | 2003-01-14 | Hvarfefni og prófanir fyrir ß-sekretasavirkni |
Country Status (11)
Country | Link |
---|---|
US (8) | US7205120B2 (is) |
EP (1) | EP1301604B1 (is) |
JP (1) | JP2004504018A (is) |
AT (1) | ATE397077T1 (is) |
AU (1) | AU2001277950A1 (is) |
CA (1) | CA2410898A1 (is) |
DE (1) | DE60134230D1 (is) |
IL (1) | IL153943A0 (is) |
IS (1) | IS6678A (is) |
TW (2) | TWI316960B (is) |
WO (1) | WO2002006306A2 (is) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19983100T1 (de) | 1998-04-06 | 2001-05-31 | Imation Corp | Herstellung eines umgekehrten optischen Masters für Datenspeicherplatten |
US7196163B2 (en) | 2001-05-22 | 2007-03-27 | Merk & Co., Inc. | Assays using amyloid precursor proteins with modified β-secretase cleavage sites to monitor β-secretase activity |
IL150601A (en) * | 2001-07-19 | 2010-06-30 | Organon Nv | Process for rapid synthesis of peptides within a solution using the back of an activated carboxyl component and destruction of the residual activated carboxyl component |
TWI243826B (en) * | 2001-07-19 | 2005-11-21 | Akzo Nobel Nv | Process for the preparation of peptides |
EP1495329B1 (en) * | 2002-04-18 | 2006-03-29 | Esbatech AG | Method for the identification of modulators of a secretase activity |
JP2004000060A (ja) * | 2002-05-31 | 2004-01-08 | Otsuka Pharmaceut Co Ltd | アミロイドβ産生に影響を与える化合物のスクリーニング方法 |
CN1742201A (zh) * | 2002-11-14 | 2006-03-01 | Qtl生物系统有限公司 | 使用荧光聚合物和猝灭剂-系链-配体生物缀合物的生物传感方法 |
US20050112696A1 (en) * | 2003-11-25 | 2005-05-26 | The University Of Texas Southwestern Medical Center | Compositions, methods and assays related to secretase cleavage specificity |
US20060098887A1 (en) * | 2004-05-19 | 2006-05-11 | Hazem El-Bakry | Mehthod for image conversion |
JP5066514B2 (ja) * | 2005-03-14 | 2012-11-07 | ハイ ポイント ファーマシューティカルズ,エルエルシー | ベンズアゾール誘導体、組成物及びβ−セクレターゼ阻害剤としての使用方法 |
DE102005051978A1 (de) * | 2005-10-31 | 2007-05-10 | Forschungszentrum Borstel Zentrum für Medizin und Biowissenschaften | Verfahren zur Bestimmung der Spaltbarkeit von Substraten |
JP4848986B2 (ja) * | 2007-03-22 | 2011-12-28 | 富士ゼロックス株式会社 | 光導波路及びその製造方法 |
US8548257B2 (en) * | 2009-01-05 | 2013-10-01 | Apple Inc. | Distinguishing between faces and non-faces |
ES2607086T3 (es) | 2010-11-10 | 2017-03-29 | F. Hoffmann-La Roche Ag | Métodos y composiciones para la inmunoterapia de enfermedades neuronales |
JP2013158281A (ja) * | 2012-02-03 | 2013-08-19 | Shionogi & Co Ltd | 新規bace1活性測定方法 |
JP6993228B2 (ja) | 2014-11-19 | 2022-03-03 | ジェネンテック, インコーポレイテッド | 抗トランスフェリン受容体/抗bace1多重特異性抗体および使用方法 |
EP3221364B1 (en) | 2014-11-19 | 2020-12-16 | Genentech, Inc. | Antibodies against bace1 and use thereof for neural disease immunotherapy |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5292652A (en) | 1990-10-05 | 1994-03-08 | Athena Neurosciences, Inc. | Amyloidin protease and uses thereof |
US5798224A (en) * | 1992-12-29 | 1998-08-25 | Doheny Eye Institute | Nucleic acids encoding protocadherin |
JP4052605B2 (ja) * | 1994-05-18 | 2008-02-27 | タカラバイオ株式会社 | α−1,3/4−フコシダーゼ遺伝子 |
WO1996040885A2 (en) * | 1995-06-07 | 1996-12-19 | Athena Neurosciences, Inc. | β-SECRETASE, ANTIBODIES TO β-SECRETASE, AND ASSAYS FOR DETECTING β-SECRETASE INHIBITION |
US6803188B1 (en) * | 1996-01-31 | 2004-10-12 | The Regents Of The University Of California | Tandem fluorescent protein constructs |
GB9701684D0 (en) | 1997-01-28 | 1997-03-19 | Smithkline Beecham Plc | Novel compounds |
WO1999040930A1 (en) * | 1998-02-12 | 1999-08-19 | Center For Blood Research, Inc. | Specific inhibitors of nfat activation by calcineurin and their use in treating immune-related diseases |
US7090976B2 (en) * | 1999-11-10 | 2006-08-15 | Rigel Pharmaceuticals, Inc. | Methods and compositions comprising Renilla GFP |
HUP0104022A2 (hu) * | 1998-06-05 | 2002-03-28 | Aventis Pharma S.A. | Béta-szekretáz típusú aktivitással rendelkező polipeptidek |
EP1100520B1 (en) * | 1998-07-21 | 2004-09-22 | Cytovia, Inc. | Novel fluorescence dyes and their applications for whole cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof |
KR100768381B1 (ko) | 1998-09-24 | 2007-10-18 | 파마시아 앤드 업존 캄파니 엘엘씨 | 알츠하이머병 세크레타제 |
US6313268B1 (en) * | 1998-10-16 | 2001-11-06 | Vivian Y. H. Hook | Secretases related to Alzheimer's dementia |
GB2364059B (en) | 1999-02-10 | 2004-01-14 | Elan Pharm Inc | Beta-Secretase enzyme compositions and methods |
WO2000058479A1 (en) | 1999-03-26 | 2000-10-05 | Amgen Inc. | Beta secretase genes and polypeptides |
US6545127B1 (en) * | 1999-06-28 | 2003-04-08 | Oklahoma Medical Research Foundation | Catalytically active recombinant memapsin and methods of use thereof |
US7429639B2 (en) * | 1999-09-29 | 2008-09-30 | Ludwig Institute For Cancer Research | SSX-2 peptides presented by HLA class II molecules |
GB9925136D0 (en) * | 1999-10-22 | 1999-12-22 | Smithkline Beecham Plc | Novel treatment |
EP1237930B1 (en) * | 1999-12-08 | 2006-11-08 | Intellect Neurosciences, Inc. | Chimeric amyloid beta peptides |
WO2001070672A2 (en) * | 2000-03-23 | 2001-09-27 | Elan Pharmaceuticals, Inc. | Compounds and methods to treat alzheimer's disease |
US20030096864A1 (en) * | 2000-06-30 | 2003-05-22 | Fang Lawrence Y. | Compounds to treat alzheimer's disease |
DE60229846D1 (de) | 2001-05-22 | 2008-12-24 | Merck & Co Inc | Beta-secretase-substrat und seine verwendung |
-
2001
- 2001-07-19 CA CA002410898A patent/CA2410898A1/en not_active Abandoned
- 2001-07-19 TW TW090117695A patent/TWI316960B/zh not_active IP Right Cessation
- 2001-07-19 EP EP01955899A patent/EP1301604B1/en not_active Expired - Lifetime
- 2001-07-19 AT AT01955899T patent/ATE397077T1/de not_active IP Right Cessation
- 2001-07-19 WO PCT/US2001/023035 patent/WO2002006306A2/en active Application Filing
- 2001-07-19 AU AU2001277950A patent/AU2001277950A1/en not_active Abandoned
- 2001-07-19 US US09/908,943 patent/US7205120B2/en not_active Expired - Fee Related
- 2001-07-19 IL IL15394301A patent/IL153943A0/xx not_active IP Right Cessation
- 2001-07-19 JP JP2002512206A patent/JP2004504018A/ja not_active Withdrawn
- 2001-07-19 TW TW095116459A patent/TW200628612A/zh unknown
- 2001-07-19 DE DE60134230T patent/DE60134230D1/de not_active Expired - Lifetime
-
2003
- 2003-01-14 IS IS6678A patent/IS6678A/is unknown
-
2004
- 2004-03-16 US US10/801,493 patent/US20050096457A1/en not_active Abandoned
- 2004-03-16 US US10/801,487 patent/US7803739B2/en not_active Expired - Fee Related
- 2004-03-16 US US10/801,509 patent/US7888291B2/en not_active Expired - Fee Related
- 2004-03-16 US US10/801,938 patent/US20040253706A1/en not_active Abandoned
- 2004-03-16 US US10/801,486 patent/US20040254342A1/en not_active Abandoned
-
2007
- 2007-03-01 US US11/713,091 patent/US20080299596A1/en not_active Abandoned
- 2007-05-24 US US11/753,331 patent/US20080090260A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20080299596A1 (en) | 2008-12-04 |
DE60134230D1 (de) | 2008-07-10 |
US7205120B2 (en) | 2007-04-17 |
US20040254342A1 (en) | 2004-12-16 |
US20040253706A1 (en) | 2004-12-16 |
US7803739B2 (en) | 2010-09-28 |
US20080090260A1 (en) | 2008-04-17 |
JP2004504018A (ja) | 2004-02-12 |
CA2410898A1 (en) | 2002-01-24 |
US20050096457A1 (en) | 2005-05-05 |
IL153943A0 (en) | 2003-07-31 |
EP1301604A2 (en) | 2003-04-16 |
TW200628612A (en) | 2006-08-16 |
US20040241792A1 (en) | 2004-12-02 |
ATE397077T1 (de) | 2008-06-15 |
TWI316960B (en) | 2009-11-11 |
US7888291B2 (en) | 2011-02-15 |
EP1301604B1 (en) | 2008-05-28 |
WO2002006306A2 (en) | 2002-01-24 |
AU2001277950A1 (en) | 2002-01-30 |
WO2002006306A3 (en) | 2002-07-25 |
US20040254341A1 (en) | 2004-12-16 |
US20030017991A1 (en) | 2003-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS6678A (is) | Hvarfefni og prófanir fyrir ß-sekretasavirkni | |
DE60144145D1 (de) | Subtilisin-variante | |
DE60325892D1 (de) | Stellungs- und verwendungsverfahren | |
ATE380822T1 (de) | Funf-helix protein | |
MXPA04003333A (es) | Remodelado y glicoconjugacion de peptidos. | |
DK1229047T3 (da) | IL-1-receptor-fusionsproteiner anvendt som antagonister og fremgangsmåder til fremstilling og anvendelse | |
IL150168A0 (en) | Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods bsed thereon | |
DK1259547T3 (da) | Højpotente, rekombinante antistoffer og fremgangsmåde til fremstilling heraf | |
NZ521396A (en) | Fusion proteins comprising two or more Neisseria polypeptides | |
DK1149905T3 (da) | Fremgangsmåder og præparat til polypeptidteknologi | |
DK1084146T3 (da) | Hybridprotein til inhibering af degranuleringen af mastocyter og anvendelse deraf | |
ATE350470T1 (de) | Durch thrombin spaltbare chimäre proteine | |
ATE382148T1 (de) | Antikörper für apoptosemarker und anwendungsverfahren | |
DK1532261T3 (da) | Fremgangsmåder og DNA-konstrukter til produktion af polypeptider med højt udbytte | |
ATE501268T1 (de) | Vorrichtungen und verfahren zur bestimmung von proteaseaktivität | |
DK372086D0 (da) | Fremgangsmaade til rekombinant-dna-syntese af en serinproteaseinhibitor og dna-sekvenser, som er nyttige derved | |
NO20052552D0 (no) | Loselige Notch-baserte substrater for gamma-sekretase og fremgangsmater og blandinger for anvendelse av samme. | |
DE60118935D1 (de) | Dna & protein bindende miniatur proteine | |
EA200400392A1 (ru) | Связывающий каспазу-8 белок, его получение и применение | |
ATE385805T1 (de) | Neue peptide | |
DK450187D0 (da) | Fremgangsmaade til fremstilling af proteiner | |
WO2000068416A3 (de) | Methoden zur auffindung von proteasen, die spezifisch membrangebundene substrate spalten | |
DK0994187T3 (da) | Renin-aktivt stof omfattende humant prorenin og antistoffer mod prorenin-profragmentet | |
ATE319839T1 (de) | Verfahren zur verbesserung der transfektionseffizienz | |
AU2003264736A1 (en) | Fiber-shaping peptides capable of interacting with self-assembling peptides |